Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Uniquity Bio Names CFO Ahead of Key Trial Readouts

Summary by MyChesCo
MALVERN, PA — Uniquity Bio has appointed former Goldman Sachs biotechnology banker Matthew Hartzell as chief financial officer as the clinical-stage biotechnology company prepares for multiple Phase II data releases …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

MyChesCoMyChesCo

Uniquity Bio Names CFO Ahead of Key Trial Readouts

MALVERN, PA — Uniquity Bio has appointed former Goldman Sachs biotechnology banker Matthew Hartzell as chief financial officer as the clinical-stage biotechnology company prepares for multiple Phase II data releases …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MyChesCo broke the news on Friday, July 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Goldman Sachs icon

Goldman Sachs

Malvern, Pennsylvania icon

Malvern, Pennsylvania

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal